{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:15:52Z","timestamp":1765545352150,"version":"3.32.0"},"publisher-location":"Berlin\/Heidelberg","reference-count":172,"publisher":"Springer-Verlag","isbn-type":[{"type":"print","value":"354022565X"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-26573-2_4","type":"book-chapter","created":{"date-parts":[[2005,12,23]],"date-time":"2005-12-23T14:25:47Z","timestamp":1135347947000},"page":"117-145","source":"Crossref","is-referenced-by-count":44,"title":["Analysis of the Endocannabinoid System by Using CB1 Cannabinoid Receptor Knockout Mice"],"prefix":"10.1007","author":[{"given":"O.","family":"Valverde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Karsak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","first-page":"1290","volume":"278","author":"M.D. Aceto","year":"1996","unstructured":"Aceto MD, Scates SM, Lowe JA, Martin BR (1996) Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J Pharmacol Exp Ther 278:1290\u20131295","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0301-0082(98)00087-2","volume":"58","author":"A. Ameri","year":"1999","unstructured":"Ameri A (1999) The effects of cannabinoids on the brain. Prog Neurobiol 58:315\u2013348","journal-title":"Prog Neurobiol"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0024-3205(01)01366-2","volume":"70","author":"J.C. Arnold","year":"2001","unstructured":"Arnold JC, Hunt GE, McGregor IS (2001) Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats. Life Sci 70:97\u2013108","journal-title":"Life Sci"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s002130050326","volume":"132","author":"M. Arnone","year":"1997","unstructured":"Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132:104\u2013106","journal-title":"Psychopharmacology"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0896-6273(00)80907-1","volume":"25","author":"M.I. Banks","year":"2000","unstructured":"Banks MI, White JA, Pearce RA (2000) Interactions between distinct GABA(A) circuits in hippocampus. Neuron 25:449\u2013457","journal-title":"Neuron"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1054\/plef.2001.0352","volume":"66","author":"B.S. Basavarajappa","year":"2002","unstructured":"Basavarajappa BS, Hungund BL (2002) Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview. Prostaglandins Leukot Essent Fatty Acids 66:287\u2013299","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev.ne.07.030184.001521","volume":"7","author":"A.I. Basbaum","year":"1984","unstructured":"Basbaum AI, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309\u2013338","journal-title":"Annu Rev Neurosci"},{"key":"4_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","volume":"7","author":"S. Batkai","year":"2001","unstructured":"Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, Wang L, Mirshahi F Khanolkar AD, Makriyannis A, Urbaschek R, Garcia N Jr, Sanyal AJ, Kunos G (2001) Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 7:827\u2013832","journal-title":"Nat Med"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"H595","DOI":"10.1152\/ajpheart.00184.2004","volume":"287","author":"S. Batkai","year":"2004","unstructured":"Batkai S, Pacher P, Jarai Z, Wagner JA, Kunos G (2004) Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors. Am J Physiol Heart Circ Physiol 287:H595\u2013H600","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/cpt1975183287","volume":"18","author":"N.L. Benowitz","year":"1975","unstructured":"Benowitz NL, Jones RT (1975) Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion. Clin Pharmacol Ther 18:287\u2013297","journal-title":"Clin Pharmacol Ther"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00426828","volume":"49","author":"H.N. Bhargava","year":"1976","unstructured":"Bhargava HN (1976a) Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice. Psychopharmacology (Berl) 49:267\u2013270","journal-title":"Psychopharmacology"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(76)90283-1","volume":"36","author":"H.N. Bhargava","year":"1976","unstructured":"Bhargava HN (1976b) Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol. Eur J Pharmacol 36:259\u2013262","journal-title":"Eur J Pharmacol"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(76)90259-4","volume":"36","author":"H.N. Bhargava","year":"1976","unstructured":"Bhargava HN, Way EL (1976) Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists. Eur J Pharmacol 36:79\u201388","journal-title":"Eur J Pharmacol"},{"key":"4_CR14","first-page":"24","volume":"172","author":"H.I. Bicher","year":"1968","unstructured":"Bicher HI, Mechoulam R (1968) Pharmacological effects of two active constituents of marihuana. Arch Int Pharmacodyn Ther 172:24\u201331","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1083\/jcb.200305129","volume":"163","author":"T. Bisogno","year":"2003","unstructured":"Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163:463\u2013468","journal-title":"J Cell Biol"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0306-4522(99)00483-2","volume":"95","author":"G.A. Bohme","year":"2000","unstructured":"Bohme GA, Laville M, Ledent C, Parmentier M, Imperato A (2000) Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95:5\u20137","journal-title":"Neuroscience"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1097\/00001756-200006260-00044","volume":"11","author":"D. Braida","year":"2000","unstructured":"Braida D, Sala M (2000) Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. Neuroreport 11:2025\u20132029","journal-title":"Neuroreport"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/sj.bjp.0704825","volume":"136","author":"D. Braida","year":"2002","unstructured":"Braida D, Sala M (2002) Role of the endocannabinoid system in MDMA intracerebral self-administration in rats. Br J Pharmacol 136:1089\u20131092","journal-title":"Br J Pharmacol"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0014-2999(01)00766-X","volume":"413","author":"D. Braida","year":"2001","unstructured":"Braida D, Pozzi M, Parolaro D, Sala M (2001) Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system. Eur J Pharmacol 413:227\u2013234","journal-title":"Eur J Pharmacol"},{"key":"4_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.60.1.155","volume":"60","author":"C.S. Breivogel","year":"2001","unstructured":"Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60:155\u2013163","journal-title":"Mol Pharmacol"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0306-4522(03)00200-8","volume":"119","author":"D. Bridges","year":"2003","unstructured":"Bridges D, Rice AS, Egertova M, Elphick MR, Winter J, Michael GJ (2003) Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience 119:803\u2013812","journal-title":"Neuroscience"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF00422507","volume":"25","author":"D.M. Buxbaum","year":"1972","unstructured":"Buxbaum DM (1972) Analgesic activity of 9-tetrahydrocannabinol in the rat and mouse. Psychopharmacologia 25:275\u2013280","journal-title":"Psychopharmacologia"},{"key":"4_CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","volume":"394","author":"A. Calignano","year":"1998","unstructured":"Calignano A, La Rana G, Giuffrida A, Piomelli D (1998) Control of pain initiation by endogenous cannabinoids. Nature 394:277\u2013281","journal-title":"Nature"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0091-3057(77)90232-5","volume":"7","author":"J.M. Carney","year":"1977","unstructured":"Carney JM, Uwaydah IM, Balster RL (1977) Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkey. Pharmacol Biochem Behav 7:357\u2013364","journal-title":"Pharmacol Biochem Behav"},{"key":"4_CR25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0028-3908(02)00118-1","volume":"43","author":"A. Casta\u00f1e","year":"2002","unstructured":"Casta\u00f1e A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43:857\u2013867","journal-title":"Neuropharmacology"},{"key":"4_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1460-9568.2003.02409.x","volume":"17","author":"A. Casta\u00f1e","year":"2003","unstructured":"Casta\u00f1e A, Robledo P, Matifas A, Kieffer BL, Maldonado R (2003) Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice. Eur J Neurosci 17:155\u2013159","journal-title":"Eur J Neurosci"},{"key":"4_CR27","first-page":"545","volume":"3","author":"L.D. Chait","year":"1992","unstructured":"Chait LD, Perry JL (1992) Factors influencing self-administration of, and subjective response to, placebo marijuana. Behav Pharmacol 3:545\u2013552","journal-title":"Behav Pharmacol"},{"key":"4_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20","volume":"13","author":"F. Chaperon","year":"1999","unstructured":"Chaperon F, Thiebot MH (1999) Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243\u2013281","journal-title":"Crit Rev Neurobiol"},{"key":"4_CR29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","volume":"13","author":"C. Cohen","year":"2002","unstructured":"Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13:451\u2013463","journal-title":"Behav Pharmacol"},{"key":"4_CR30","first-page":"586","volume":"277","author":"D.R. Compton","year":"1996","unstructured":"Compton DR, Aceto MD, Lowe J, Martin BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586\u2013594","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR31","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0022-3565(24)37499-3","volume":"285","author":"S.A. Cook","year":"1998","unstructured":"Cook SA, Lowe JA, Martin BR (1998) CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 285:1150\u20131156","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00429580","volume":"35","author":"M.E. Corcoran","year":"1974","unstructured":"Corcoran ME, Amit Z (1974) Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacologia 35:129\u2013147","journal-title":"Psychopharmacologia"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0166-4328(00)00311-9","volume":"118","author":"G. Cossu","year":"2001","unstructured":"Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M, Fratta W (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118:61\u201365","journal-title":"Behav Brain Res"},{"key":"4_CR34","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1001-1151","volume":"7","author":"T.J. Vries De","year":"2001","unstructured":"De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJ, Schoffelmeer AN (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7:1151\u20131154","journal-title":"Nat Med"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1523\/JNEUROSCI.23-06-02371.2003","volume":"23","author":"P. Derkinderen","year":"2003","unstructured":"Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H, Ledent C, Trzaskos J, Caboche J, Girault JA (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci 23:2371\u20132382","journal-title":"J Neurosci"},{"key":"4_CR36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s002130100804","volume":"157","author":"V. Deroche-Gamonet","year":"2001","unstructured":"Deroche-Gamonet V, Le Moal M, Piazza PV, Soubrie P (2001) SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats. Psychopharmacology (Berl) 157:254\u2013259","journal-title":"Psychopharmacology"},{"key":"4_CR37","first-page":"151","volume":"38","author":"W.L. Dewey","year":"1986","unstructured":"Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38:151\u2013178","journal-title":"Pharmacol Rev"},{"key":"4_CR38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/026988119801200108","volume":"12","author":"G. Chiara Di","year":"1998","unstructured":"Di Chiara G (1998) A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. J Psychopharmacol 12:54\u201367","journal-title":"J Psychopharmacol"},{"key":"4_CR39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","volume":"21","author":"V. Marzo Di","year":"1998","unstructured":"Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521\u2013528","journal-title":"Trends Neurosci"},{"key":"4_CR40","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1046\/j.1471-4159.2000.0752434.x","volume":"75","author":"V. Marzo Di","year":"2000","unstructured":"Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR (2000) Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem 75:2434\u20132444","journal-title":"J Neurochem"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"V. Marzo Di","year":"2001","unstructured":"Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410:822\u2013825","journal-title":"Nature"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.bjp.0705726","volume":"142","author":"M.A. Diana","year":"2004","unstructured":"Diana MA, Marty A (2004) Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 142:9\u201319","journal-title":"Br J Pharmacol"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0006-8993(95)01113-7","volume":"706","author":"F. Fan","year":"1996","unstructured":"Fan F, Tao Q, Abood M, Martin BR (1996) Cannabinoid receptor down-regulation without alteration of the inhibitory effect of CP 55,940 on adenylyl cyclase in the cerebellum of CP 55,940-tolerant mice. Brain Res 706:13\u201320","journal-title":"Brain Res"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0166-4328(99)00059-5","volume":"104","author":"L. Fattore","year":"1999","unstructured":"Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W (1999) CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 104:141\u2013146","journal-title":"Behav Brain Res"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1046\/j.1460-9568.2003.02607.x","volume":"17","author":"L. Fattore","year":"2003","unstructured":"Fattore L, Spano MS, Cossu G, Deiana S, Fratta W (2003) Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci 17:1723\u20131726","journal-title":"Eur J Neurosci"},{"key":"4_CR46","first-page":"430","volume":"5","author":"J.R. Fernandez","year":"2004","unstructured":"Fernandez JR, Allison DB (2004) Rimonabant Sanofi-Synthelabo. Curr Opin Investig Drugs 5:430\u2013435","journal-title":"Curr Opin Investig Drugs"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev.ne.14.030191.001251","volume":"14","author":"H.L. Fields","year":"1991","unstructured":"Fields HL, Heinricher MM, Mason P (1991) Neurotransmitters in nociceptive modulatory circuits. Annu Rev Neurosci 14:219\u2013245","journal-title":"Annu Rev Neurosci"},{"key":"4_CR48","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1530-0277.2001.tb02209.x","volume":"25","author":"C.S. Freedland","year":"2001","unstructured":"Freedland CS, Sharpe AL, Samsonz HH, Porrino LJ (2001) Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res 25:277\u2013282","journal-title":"Alcohol Clin Exp Res"},{"key":"4_CR49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","volume":"83","author":"T.F. Freund","year":"2003","unstructured":"Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017\u20131066","journal-title":"Physiol Rev"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0014-2999(01)00953-0","volume":"419","author":"E. Fride","year":"2001","unstructured":"Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R (2001) Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur J Pharmacol 419:207\u2013214","journal-title":"Eur J Pharmacol"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0014-2999(03)01295-0","volume":"461","author":"E. Fride","year":"2003","unstructured":"Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R (2003) Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a \u201cCB3\u201d receptor. Eur J Pharmacol 461:27\u201334","journal-title":"Eur J Pharmacol"},{"key":"4_CR52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02431546","volume":"96","author":"E.L. Gardner","year":"1988","unstructured":"Gardner EL, Paredes W, Smith D, Donner A, Milling C, Cohen D, Morrison D (1988) Facilitation of brain stimulation reward by delta 9-tetrahydrocannabinol. Psychopharmacology (Berl) 96:142\u2013144","journal-title":"Psychopharmacology"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","volume":"15","author":"C.R. Gerfen","year":"1992","unstructured":"Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133\u2013139","journal-title":"Trends Neurosci"},{"key":"4_CR54","first-page":"82","volume":"125","author":"C.R. Gerfen","year":"1993","unstructured":"Gerfen CR (1993) Functional organization of the striatum: relevance to actions of psychostimulant drugs of abuse. NIDA Res Monogr 125:82\u201391","journal-title":"NIDA Res Monogr"},{"key":"4_CR55","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1523\/JNEUROSCI.22-03-01146.2002","volume":"22","author":"S. Ghozland","year":"2002","unstructured":"Ghozland S, Matthes HW, Simonin F, Filliol D, Kieffer BL, Maldonado R (2002) Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 22:1146\u20131154","journal-title":"J Neurosci"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0968-0004(01)01921-1","volume":"26","author":"T. Grutter","year":"2001","unstructured":"Grutter T, Changeux JP (2001) Nicotinic receptors in wonderland. Trends Biochem Sci 26:459\u2013463","journal-title":"Trends Biochem Sci"},{"key":"4_CR57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(02)02485-8","volume":"454","author":"H. Guhring","year":"2002","unstructured":"Guhring H, Hamza M, Sergejeva M, Ates M, Kotalla CE, Ledent C, Brune K (2002) A role for endocannabinoids in indomethacin-induced spinal antinociception. Eur J Pharmacol 454:153\u2013163","journal-title":"Eur J Pharmacol"},{"key":"4_CR58","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","volume":"12","author":"N. Hajos","year":"2000","unstructured":"Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF (2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12:3239\u20133249","journal-title":"Eur J Neurosci"},{"key":"4_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4522(01)00287-1","volume":"106","author":"N. Hajos","year":"2001","unstructured":"Hajos N, Ledent C, Freund TF (2001) Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1\u20134","journal-title":"Neuroscience"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1046\/j.1460-9568.2002.02192.x","volume":"16","author":"J. Haller","year":"2002","unstructured":"Haller J, Bakos N, Szirmay M, Ledent C, Freund TF (2002) The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci 16:1395\u20131398","journal-title":"Eur J Neurosci"},{"key":"4_CR61","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1523\/JNEUROSCI.20-23-08932.2000","volume":"20","author":"R.E. Hampson","year":"2000","unstructured":"Hampson RE, Deadwyler SA (2000) Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci 20:8932\u20138942","journal-title":"J Neurosci"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1073\/pnas.96.25.14228","volume":"96","author":"L. Hanus","year":"1999","unstructured":"Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E (1999) HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc Natl Acad Sci U S A 96:14228\u201314233","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF00426679","volume":"37","author":"R.T. Harris","year":"1974","unstructured":"Harris RT, Waters W, McLendon D (1974) Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in rhesus monkeys. Psychopharmacologia 37:23\u201329","journal-title":"Psychopharmacologia"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1079\/BJN2003942","volume":"90","author":"J.A. Harrold","year":"2003","unstructured":"Harrold JA, Williams G (2003) The cannabinoid system: a role in both the homeostatic and hedonic control of eating? Br J Nutr 90:729\u2013734","journal-title":"Br J Nutr"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0304-3940(96)13308-5","volume":"221","author":"U. Herzberg","year":"1997","unstructured":"Herzberg U, Eliav E, Bennett GJ, Kopin IJ (1997) The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 221:157\u2013160","journal-title":"Neurosci Lett"},{"key":"4_CR66","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00213-002-1263-3","volume":"165","author":"S. Higgs","year":"2003","unstructured":"Higgs S, Williams CM, Kirkham TC (2003) Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl) 165:370\u2013377","journal-title":"Psychopharmacology"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s002130050200","volume":"129","author":"B.E. Hildebrand","year":"1997","unstructured":"Hildebrand BE, Nomikos GG, Bondjers C, Nisell M, Svensson TH (1997) Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms. Psychopharmacology (Berl) 129:348\u2013356","journal-title":"Psychopharmacology"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/0024-3205(75)90435-X","volume":"17","author":"B. Hine","year":"1975","unstructured":"Hine B, Torrelio M, Gershon S (1975) Interactions between cannabidiol and delta9-THC during abstinence in morphine-dependent rats. Life Sci 17:851\u2013857","journal-title":"Life Sci"},{"key":"4_CR69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-3084(02)00154-8","volume":"121","author":"A.G. Hohmann","year":"2002","unstructured":"Hohmann AG (2002) Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem Phys Lipids 121:173\u2013190","journal-title":"Chem Phys Lipids"},{"key":"4_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(98)00534-5","volume":"252","author":"A.G. Hohmann","year":"1998","unstructured":"Hohmann AG, Herkenham M (1998) Regulation of cannabinoid andmu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment. Neurosci Lett 252:13\u201316","journal-title":"Neurosci Lett"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/0024-3205(95)00196-D","volume":"56","author":"A.G. Hohmann","year":"1995","unstructured":"Hohmann AG, Martin WJ, Tsou K, Walker JM (1995) Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci 56:2111\u20132118","journal-title":"Life Sci"},{"key":"4_CR72","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1046\/j.1471-4159.2003.01576.x","volume":"84","author":"B.L. Hungund","year":"2003","unstructured":"Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C (2003) Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 84:698\u2013704","journal-title":"J Neurochem"},{"key":"4_CR73","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/sj.bjp.0702228","volume":"125","author":"D.M. Hutcheson","year":"1998","unstructured":"Hutcheson DM, Tzavara ET, Smadja C, Valjent E, Roques BP, Hanoune J, Maldonado R (1998) Behavioural and biochemical evidence for signs of abstinence in mice chronically treated with delta-9-tetrahydrocannabinol. Br J Pharmacol 125:1567\u20131577","journal-title":"Br J Pharmacol"},{"key":"4_CR74","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0304-3959(98)00041-4","volume":"76","author":"S.I. Jaggar","year":"1998","unstructured":"Jaggar SI, Hasnie FS, Sellaturay S, Rice AS (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain 76:189\u2013199","journal-title":"Pain"},{"key":"4_CR75","doi-asserted-by":"publisher","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","volume":"96","author":"Z. Jarai","year":"1999","unstructured":"Jarai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G (1999) Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci U S A 96:14136\u201314141","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR76","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.HYP.35.2.679","volume":"35","author":"Z. Jarai","year":"2000","unstructured":"Jarai Z, Wagner JA, Goparaju SK, Wang L, Razdan RK, Sugiura T, Zimmer AM, Bonner TI, Zimmer A, Kunos G (2000) Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension 35:679\u2013684","journal-title":"Hypertension"},{"key":"4_CR77","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00213-003-1484-0","volume":"169","author":"Z. Justinova","year":"2003","unstructured":"Justinova Z, Tanda G, Redhi GH, Goldberg SR (2003) Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology (Berl) 169:135\u2013140","journal-title":"Psychopharmacology"},{"key":"4_CR78","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-003-1693-6","volume":"173","author":"Z. Justinova","year":"2004","unstructured":"Justinova Z, Tanda G, Munzar P, Goldberg SR (2004) The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) insquirrelmonkeys. Psychopharmacology (Berl) 173:186\u2013194","journal-title":"Psychopharmacology"},{"key":"4_CR79","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/sj.bjp.0703987","volume":"132","author":"M. Kathmann","year":"2001","unstructured":"Kathmann M, Weber B, Zimmer A, Schlicker E (2001) Enhanced acetylcholine release in the hippocampus of cannabinoid CB(1) receptor-deficient mice. Br J Pharmacol 132:1169\u20131173","journal-title":"Br J Pharmacol"},{"key":"4_CR80","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","volume":"19","author":"I. Katona","year":"1999","unstructured":"Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF (1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19:4544\u20134558","journal-title":"J Neurosci"},{"key":"4_CR81","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00497855","volume":"55","author":"S. Kaymakcalan","year":"1977","unstructured":"Kaymakcalan S, Ayhan IH, Tulunay FC (1977) Naloxone-induced or postwithdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats. Psychopharmacology (Berl) 55:243\u2013249","journal-title":"Psychopharmacology"},{"key":"4_CR82","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1152\/jn.2001.86.6.3061","volume":"86","author":"S. Kelly","year":"2001","unstructured":"Kelly S, Chapman V (2001) Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J Neurophysiol 86:3061\u20133064","journal-title":"J Neurophysiol"},{"key":"4_CR83","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","volume":"136","author":"T.C. Kirkham","year":"2002","unstructured":"Kirkham TC, Williams CM, Fezza F, Di Marzo V (2002) Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol 136:550\u2013557","journal-title":"Br J Pharmacol"},{"key":"4_CR84","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s002130050955","volume":"143","author":"M.C. Ko","year":"1999","unstructured":"Ko MC, Woods JH (1999) Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action. Psychopharmacology (Berl) 143:322\u2013326","journal-title":"Psychopharmacology"},{"key":"4_CR85","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.HYP.29.5.1204","volume":"29","author":"K.D. Lake","year":"1997","unstructured":"Lake KD, Martin BR, Kunos G, Varga K (1997) Cardiovascular effects of anandamide in anesthetized and conscious normotensive and hypertensive rats. Hypertension 29:1204\u20131210","journal-title":"Hypertension"},{"key":"4_CR86","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1073\/pnas.042699699","volume":"99","author":"N. Novere Le","year":"2002","unstructured":"Le Novere N, Grutter T, Changeux JP (2002) Models of the extracellular domain of the nicotinic receptors and of agonist-and Ca2+-binding sites. Proc Natl Acad Sci U S A 99:3210\u20133215","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR87","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1126\/science.283.5400.401","volume":"283","author":"C. Ledent","year":"1999","unstructured":"Ledent C, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, Bohme GA, Imperato A, Pedrazzini T, Roques BP, Vassart G, Fratta W, Parmentier M (1999) Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283:401\u2013404","journal-title":"Science"},{"key":"4_CR88","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/0024-3205(95)00191-8","volume":"56","author":"M. Lepore","year":"1995","unstructured":"Lepore M, Vorel SR, Lowinson J, Gardner EL (1995) Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci 56:2073\u20132080","journal-title":"Life Sci"},{"key":"4_CR89","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0024-3205(96)00237-8","volume":"58","author":"M. Lepore","year":"1996","unstructured":"Lepore M, Liu X, Savage V, Matalon D, Gardner EL (1996) Genetic differences in delta 9-tetrahydrocannabinol-induced facilitation of brain stimulation reward as measured by a rate-frequency curve-shift electrical brain stimulation paradigm in three different rat strains. Life Sci 58:PL365\u2013372","journal-title":"Life Sci"},{"key":"4_CR90","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3959(98)00263-2","volume":"81","author":"J. Li","year":"1999","unstructured":"Li J, Daughters RS, Bullis C, Bengiamin R, Stucky MW, Brennan J, Simone DA (1999) The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats. Pain 81:25\u201333","journal-title":"Pain"},{"key":"4_CR91","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02246347","volume":"126","author":"A.H. Lichtman","year":"1996","unstructured":"Lichtman AH, Martin BR (1996) Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology (Berl) 126:125\u2013131","journal-title":"Psychopharmacology"},{"key":"4_CR92","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.1002\/j.1552-4604.2002.tb05999.x","volume":"42","author":"A.H. Lichtman","year":"2002","unstructured":"Lichtman AH, Martin BR (2002) Marijuana withdrawal syndrome in the animal model. J Clin Pharmacol 42:20S\u201327S","journal-title":"J Clin Pharmacol"},{"key":"4_CR93","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29469-6","volume":"298","author":"A.H. Lichtman","year":"2001","unstructured":"Lichtman AH, Sheikh SM, Loh HH, Martin BR (2001) Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice. J Pharmacol Exp Ther 298:1007\u20131014","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR94","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1471-4159.2001.00413.x","volume":"78","author":"M. Maccarrone","year":"2001","unstructured":"Maccarrone M, Attina M, Bari M, Cartoni A, Ledent C, Finazzi-Agro A (2001) Anandamide degradation and N-acylethanolamines level in wild-type and CB1 cannabinoid receptor knockout mice of different ages. J Neurochem 78:339\u2013348","journal-title":"J Neurochem"},{"key":"4_CR95","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1046\/j.1460-9568.2002.01957.x","volume":"15","author":"M. Maccarrone","year":"2002","unstructured":"Maccarrone M, Valverde O, Barbaccia ML, Casta\u00f1e A, Maldonado R, Ledent C, Parmentier M, Finazzi-Agro A (2002) Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur J Neurosci 15:1178\u20131186","journal-title":"Eur J Neurosci"},{"key":"4_CR96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3940(92)90832-R","volume":"148","author":"P. Mailleux","year":"1992","unstructured":"Mailleux P, Vanderhaeghen JJ (1992) Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci Lett 148:173\u2013176","journal-title":"Neurosci Lett"},{"key":"4_CR97","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0009-3084(02)00155-X","volume":"121","author":"T.P. Malan Jr","year":"2002","unstructured":"Malan TP Jr, Ibrahim MM, Vanderah TW, Makriyannis A, Porreca F (2002) Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Chem Phys Lipids 121:191\u2013200","journal-title":"Chem Phys Lipids"},{"key":"4_CR98","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1523\/JNEUROSCI.22-09-03326.2002","volume":"22","author":"R. Maldonado","year":"2002","unstructured":"Maldonado R, Rodriguez de Fonseca F (2002) Cannabinoid addiction: behavioral models and neural correlates. J Neurosci 22:3326\u20133331","journal-title":"J Neurosci"},{"key":"4_CR99","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s002130050733","volume":"140","author":"P.E. Mallet","year":"1998","unstructured":"Mallet PE, Beninger RJ (1998) The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Psychopharmacology (Berl) 140:11\u201319","journal-title":"Psychopharmacology"},{"key":"4_CR100","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF02247436","volume":"124","author":"R.S. Mansbach","year":"1996","unstructured":"Mansbach RS, Rovetti CC, Winston EN, Lowe JA 3rd (1996) Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats. Psychopharmacology (Berl) 124:315\u2013322","journal-title":"Psychopharmacology"},{"key":"4_CR101","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(99)00998-2","volume":"280","author":"J. Mao","year":"2000","unstructured":"Mao J, Price DD, Lu J, Keniston L, Mayer DJ (2000) Two distinctive antinociceptive systems in rats with pathological pain. Neurosci Lett 280:13\u201316","journal-title":"Neurosci Lett"},{"key":"4_CR102","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","volume":"11","author":"G. Marsicano","year":"1999","unstructured":"Marsicano G, Lutz B (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11:4213\u20134225","journal-title":"Eur J Neurosci"},{"key":"4_CR103","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature00839","volume":"418","author":"G. Marsicano","year":"2002","unstructured":"Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgansberger W, Di Marzo V, Lutz B (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418:530\u2013534","journal-title":"Nature"},{"key":"4_CR104","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0306-4522(98)00052-9","volume":"85","author":"M.C. Martellotta","year":"1998","unstructured":"Martellotta MC, Cossu G, Fattore L, Gessa GL, Fratta W (1998) Self-administration of the cannabinoid receptor agonist WIN 55,212-2 in drug-naive mice. Neuroscience 85:327\u2013330","journal-title":"Neuroscience"},{"key":"4_CR105","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1006\/nbdi.1998.0218","volume":"5","author":"B.R. Martin","year":"1998","unstructured":"Martin BR, Lichtman AH (1998) Cannabinoid transmission and pain perception. Neurobiol Dis 5:447\u2013461","journal-title":"Neurobiol Dis"},{"key":"4_CR106","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1046\/j.1460-9568.2000.00287.x","volume":"12","author":"M. Martin","year":"2000","unstructured":"Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2000) Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice. Eur J Neurosci 12:4038\u20134046","journal-title":"Eur J Neurosci"},{"key":"4_CR107","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","volume":"159","author":"M. Martin","year":"2002","unstructured":"Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl) 159:379\u2013387","journal-title":"Psychopharmacology"},{"key":"4_CR108","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1523\/JNEUROSCI.16-20-06601.1996","volume":"16","author":"W.J. Martin","year":"1996","unstructured":"Martin WJ, Hohmann AG, Walker JM (1996) Suppression of noxious stimulus-evoked activity in the ventral posterolateral nucleus of the thalamus by a cannabinoid agonist: correlation between electrophysiological and antinociceptive effects. J Neurosci 16:6601\u20136611","journal-title":"J Neurosci"},{"key":"4_CR109","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0304-3959(99)00045-7","volume":"82","author":"W.J. Martin","year":"1999","unstructured":"Martin WJ, Loo CM, Basbaum AI (1999) Spinal cannabinoids are anti-allodynic in rats with persistent inflammation. Pain 82:199\u2013205","journal-title":"Pain"},{"key":"4_CR110","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/sj.bjp.0703990","volume":"132","author":"M. Mas-Nieto","year":"2001","unstructured":"Mas-Nieto M, Pommier B, Tzavara ET, Caneparo A, Da Nascimento S, Le Fur G, Roques BP, Noble F (2001) Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction. Br J Pharmacol 132:1809\u20131816","journal-title":"Br J Pharmacol"},{"key":"4_CR111","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI200419465","volume":"113","author":"F. Massa","year":"2004","unstructured":"Massa F, Marsicano G, Hermann H, Cannich A, Monory K, Cravatt BF, Ferri GL, Sibaev A, Storr M, Lutz B (2004) The endogenous cannabinoid system protects against colonic inflammation. J Clin Invest 113:1202\u20131209","journal-title":"J Clin Invest"},{"key":"4_CR112","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008877-199907000-00010","volume":"10","author":"J.M. Masserano","year":"1999","unstructured":"Masserano JM, Karoum F, Wyatt RJ (1999) SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine. Behav Pharmacol 10:429\u2013432","journal-title":"Behav Pharmacol"},{"key":"4_CR113","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0014-2999(96)00015-5","volume":"300","author":"S. Mazzari","year":"1996","unstructured":"Mazzari S, Canella R, Petrelli L, Marcolongo G, Leon A (1996) N-(2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol 300:227\u2013236","journal-title":"Eur J Pharmacol"},{"key":"4_CR114","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2004.00564.x","volume":"99","author":"J. McCambridge","year":"2004","unstructured":"McCambridge J, Strang J (2004) The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 99:39\u201352","journal-title":"Addiction"},{"key":"4_CR115","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0165-6147(03)00107-X","volume":"24","author":"R. Mechoulam","year":"2003","unstructured":"Mechoulam R, Parker L (2003) Cannabis and alcohol\u2014a close friendship. Trends Pharmacol Sci 24:266\u2013268","journal-title":"Trends Pharmacol Sci"},{"key":"4_CR116","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1037\/0033-2909.93.3.441","volume":"93","author":"L.L. Miller","year":"1983","unstructured":"Miller LL, Branconnier RJ (1983) Cannabis: effects on memory and the cholinergic limbic system. Psychol Bull 93:441\u2013456","journal-title":"Psychol Bull"},{"key":"4_CR117","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/sj.bjp.0703919","volume":"132","author":"P.J. Millns","year":"2001","unstructured":"Millns PJ, Chapman V, Kendall DA (2001) Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br J Pharmacol 132:969\u2013971","journal-title":"Br J Pharmacol"},{"key":"4_CR118","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0031-9384(94)00201-F","volume":"57","author":"F. Molina-Holgado","year":"1995","unstructured":"Molina-Holgado F, Gonzalez MI, Leret ML (1995) Effect of delta 9-tetrahydrocannabinol on short-term memory in the rat. Physiol Behav 57:177\u2013179","journal-title":"Physiol Behav"},{"key":"4_CR119","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuropharm.2003.09.002","volume":"46","author":"M. Naassila","year":"2004","unstructured":"Naassila M, Pierrefiche O, Ledent C, Daoust M (2004) Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 46:243\u2013253","journal-title":"Neuropharmacology"},{"key":"4_CR120","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","volume":"21","author":"M. Navarro","year":"2001","unstructured":"Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F (2001) Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 21:5344\u20135350","journal-title":"J Neurosci"},{"key":"4_CR121","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0149-7634(97)00053-5","volume":"22","author":"R.J. Nelson","year":"1998","unstructured":"Nelson RJ, Young KA (1998) Behavior in mice with targeted disruption of single genes. Neurosci Biobehav Rev 22:453\u2013462","journal-title":"Neurosci Biobehav Rev"},{"key":"4_CR122","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/0091-3057(86)90156-5","volume":"25","author":"R. Nemeth-Coslett","year":"1986","unstructured":"Nemeth-Coslett R, Henningfield JE, O\u2019Keeffe MK, Griffiths RR (1986) Effects of marijuana smoking on subjective ratings and tobacco smoking. Pharmacol Biochem Behav 25:659\u2013665","journal-title":"Pharmacol Biochem Behav"},{"key":"4_CR123","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1523\/JNEUROSCI.22-10-03864.2002","volume":"22","author":"T. Ohno-Shosaku","year":"2002","unstructured":"Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A, Kano M (2002) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J Neurosci 22:3864\u20133872","journal-title":"J Neurosci"},{"key":"4_CR124","doi-asserted-by":"crossref","unstructured":"Parker LA, Burton P, Sorge RE, Yakiwchuk C, Mechoulam R (2004) Effect of low doses of Delta(9)-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats. Psychopharmacology (Berl) May 11 [Epub ahead of print]","DOI":"10.1007\/s00213-004-1825-7"},{"key":"4_CR125","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","volume":"63","author":"R.G. Pertwee","year":"2001","unstructured":"Pertwee RG (2001) Cannabinoid receptors and pain. Prog Neurobiol 63:569\u2013611","journal-title":"Prog Neurobiol"},{"key":"4_CR126","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3109\/07853899809029939","volume":"30","author":"E.M. Pich","year":"1998","unstructured":"Pich EM, Epping-Jordan MP (1998) Transgenic mice in drug dependence research. Ann Med 30:390\u2013396","journal-title":"Ann Med"},{"key":"4_CR127","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1523\/JNEUROSCI.12-10-04122.1992","volume":"12","author":"T.A. Pitler","year":"1992","unstructured":"Pitler TA, Alger BE (1992) Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J Neurosci 12:4122\u20134132","journal-title":"J Neurosci"},{"key":"4_CR128","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/0896-6273(94)90430-8","volume":"13","author":"T.A. Pitler","year":"1994","unstructured":"Pitler TA, Alger BE (1994) Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 13:1447\u20131455","journal-title":"Neuron"},{"key":"4_CR129","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1523\/JNEUROSCI.23-06-02453.2003","volume":"23","author":"I. Racz","year":"2003","unstructured":"Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A (2003) A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 23:2453\u20132458","journal-title":"J Neurosci"},{"key":"4_CR130","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1016\/S0014-2999(99)00496-3","volume":"379","author":"M. Reibaud","year":"1999","unstructured":"Reibaud M, Obinu MC, Ledent C, Parmentier M, B\u00f6hme GA, Imperato A (1999) Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol 379:R1\u2013R2","journal-title":"Eur J Pharmacol"},{"key":"4_CR131","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0014-2999(97)01621-X","volume":"345","author":"J.D. Richardson","year":"1998","unstructured":"Richardson JD, Aanonsen L, Hargreaves KM (1998) Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345:145\u2013153","journal-title":"Eur J Pharmacol"},{"key":"4_CR132","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1124\/jpet.104.067884","volume":"310","author":"M. Rinaldi-Carmona","year":"2004","unstructured":"Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Perio A, Poncelet M, Maruani J, Arnone M, Finance O, Soubrie P, Le Fur G (2004) SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyr azole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization. J Pharmacol Exp Ther 310:905\u2013914","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR133","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0091-3057(94)90108-2","volume":"47","author":"F. Rodriguez Fonseca de","year":"1994","unstructured":"Rodriguez de Fonseca F, Gorriti MA, Fernandez-Ruiz JJ, Palomo T, Ramos JA (1994) Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment. Pharmacol Biochem Behav 47:33\u201340","journal-title":"Pharmacol Biochem Behav"},{"key":"4_CR134","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1006\/nbdi.1998.0217","volume":"5","author":"F. Rodriguez Fonseca de","year":"1998","unstructured":"Rodriguez de Fonseca F, Del Arco I, Martin-Calderon JL, Gorriti MA, Navarro M (1998) Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol Dis 5:483\u2013501","journal-title":"Neurobiol Dis"},{"key":"4_CR135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/JMN:11:2:109","volume":"11","author":"J. Romero","year":"1998","unstructured":"Romero J, Berrendero F, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ (1998) Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. J Mol Neurosci 11:109\u2013119","journal-title":"J Mol Neurosci"},{"key":"4_CR136","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00001756-199412000-00022","volume":"5","author":"T. Rubino","year":"1994","unstructured":"Rubino T, Massi P, Patrini G, Venier I, Giagnoni G, Parolaro D (1994) Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study. Neuroreport 5:2493\u20132496","journal-title":"Neuroreport"},{"key":"4_CR137","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-3565(24)37424-5","volume":"285","author":"T. Rubino","year":"1998","unstructured":"Rubino T, Patrini G, Massi P, Fuzio D, Vigano D, Giagnoni G, Parolaro D (1998) Cannabinoidp-recipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J Pharmacol Exp Ther 285:813\u2013819","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR138","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1046\/j.1471-4159.2000.0752478.x","volume":"75","author":"T. Rubino","year":"2000","unstructured":"Rubino T, Vigano D, Costa B, Colleoni M, Parolaro D (2000) Loss of cannabinoid-stimulated guanosine 5\u2032O-(3-[(35)S]thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. J Neurochem 75:2478\u20132484","journal-title":"J Neurochem"},{"key":"4_CR139","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1006\/meth.1998.0593","volume":"14","author":"B. Sauer","year":"1998","unstructured":"Sauer B (1998) Inducible gene targeting in mice using the Cre\/lox system. Methods 14:381\u2013392","journal-title":"Methods"},{"key":"4_CR140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0376-8716(01)00164-8","volume":"65","author":"L.G. Schmidt","year":"2002","unstructured":"Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, Wendel B, Rommelspacher H, Hoehe MR (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 65:221\u2013224","journal-title":"Drug Alcohol Depend"},{"key":"4_CR141","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","volume":"16","author":"L.J. Sim","year":"1996","unstructured":"Sim LJ, Hampson RE, Deadwyler SA, Childers SR (1996) Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 16:8057\u20138066","journal-title":"J Neurosci"},{"key":"4_CR142","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0091-3057(97)00583-2","volume":"60","author":"F.L. Smith","year":"1998","unstructured":"Smith FL, Fujimori K, Lowe J, Welch SP (1998) Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Pharmacol Biochem Behav 60:183\u2013191","journal-title":"Pharmacol Biochem Behav"},{"key":"4_CR143","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s002210050545","volume":"123","author":"H. Steiner","year":"1998","unstructured":"Steiner H, Gerfen CR (1998) Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123:60\u201376","journal-title":"Exp Brain Res"},{"key":"4_CR144","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.1073\/pnas.96.10.5786","volume":"96","author":"H. Steiner","year":"1999","unstructured":"Steiner H, Bonner TI, Zimmer AM, Kitai ST, Zimmer A (1999) Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice [see comments]. Proc Natl Acad Sci U S A 96:5786\u20135790","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR145","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","volume":"388","author":"N. Stella","year":"1997","unstructured":"Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773\u2013778","journal-title":"Nature"},{"key":"4_CR146","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0006-8993(98)01031-2","volume":"813","author":"N.M. Strangman","year":"1998","unstructured":"Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM (1998) Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res 813:323\u2013328","journal-title":"Brain Res"},{"key":"4_CR147","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/80577","volume":"3","author":"G. Tanda","year":"2000","unstructured":"Tanda G, Munzar P, Goldberg SR (2000) Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nat Neurosci 3:1073\u20131074","journal-title":"Nat Neurosci"},{"key":"4_CR148","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1016\/0014-2999(95)00360-W","volume":"280","author":"K. Tsou","year":"1995","unstructured":"Tsou K, Patrick SL, Walker JM (1995) Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist. Eur J Pharmacol 280:R13\u201315","journal-title":"Eur J Pharmacol"},{"key":"4_CR149","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0306-4522(96)83015-6","volume":"70","author":"K. Tsou","year":"1996","unstructured":"Tsou K, Lowitz KA, Hohmann AG, Martin WJ, Hathaway CB, Bereiter DA, Walker JM (1996) Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist. Neuroscience 70:791\u2013798","journal-title":"Neuroscience"},{"key":"4_CR150","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0306-4522(99)00086-X","volume":"93","author":"K. Tsou","year":"1999","unstructured":"Tsou K, Mackie K, Sanudo-Pena MC, Walker JM (1999) Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93:969\u2013975","journal-title":"Neuroscience"},{"key":"4_CR151","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/sj.bjp.0705100","volume":"138","author":"E.T. Tzavara","year":"2003","unstructured":"Tzavara ET, Davis RJ, Perry KW, Li X, Salhoff C, Bymaster FP, Witkin JM, Nomikos GG (2003) The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br J Pharmacol 138:544\u2013553","journal-title":"Br J Pharmacol"},{"key":"4_CR152","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.neuropharm.2004.01.003","volume":"46","author":"L. Uriguen","year":"2004","unstructured":"Uriguen L, Perez-Rial S, Ledent C, Palomo T, Manzanares J (2004) Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46:966\u2013973","journal-title":"Neuropharmacology"},{"key":"4_CR153","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s002130050013","volume":"147","author":"E. Valjent","year":"2000","unstructured":"Valjent E, Maldonado R (2000) A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 147:436\u2013438","journal-title":"Psychopharmacology"},{"key":"4_CR154","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/sj.bjp.0704479","volume":"135","author":"E. Valjent","year":"2002","unstructured":"Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R (2002) Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564\u2013578","journal-title":"Br J Pharmacol"},{"key":"4_CR155","doi-asserted-by":"crossref","first-page":"9284","DOI":"10.1523\/JNEUROSCI.20-24-09284.2000","volume":"20","author":"O. Valverde","year":"2000","unstructured":"Valverde O, Maldonado R, Valjent E, Zimmer AM, Zimmer A (2000a) Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-outmice. J Neurosci 20:9284\u20139289","journal-title":"J Neurosci"},{"key":"4_CR156","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1046\/j.1460-9568.2000.00929.x","volume":"12","author":"O. Valverde","year":"2000","unstructured":"Valverde O, Ledent C, Beslot F, Parmentier M, Roques BP (2000b) Reduction of stressinduced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. Eur J Neurosci 12:533\u2013539","journal-title":"Eur J Neurosci"},{"key":"4_CR157","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0014-2999(95)00181-J","volume":"278","author":"K. Varga","year":"1995","unstructured":"Varga K, Lake K, Martin BR, Kunos G (1995) Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide. Eur J Pharmacol 278:279\u2013283","journal-title":"Eur J Pharmacol"},{"key":"4_CR158","doi-asserted-by":"crossref","first-page":"RC188","DOI":"10.1523\/JNEUROSCI.21-24-j0003.2001","volume":"21","author":"N. Varma","year":"2001","unstructured":"Varma N, Carlson GC, Ledent C, Alger BE (2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21:RC188","journal-title":"J Neurosci"},{"key":"4_CR159","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1124\/jpet.301.3.915","volume":"301","author":"S.A. Varvel","year":"2002","unstructured":"Varvel SA, Lichtman AH (2002) Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301:915\u2013924","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR160","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/0028-3908(95)00032-2","volume":"34","author":"G. Vela","year":"1995","unstructured":"Vela G, Ruiz-Gayo M, Fuentes JA (1995) Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine. Neuropharmacology 34:665\u2013668","journal-title":"Neuropharmacology"},{"key":"4_CR161","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0166-4328(02)00370-4","volume":"141","author":"S. Vlachou","year":"2003","unstructured":"Vlachou S, Nomikos GG, Panagis G (2003) WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation. Behav Brain Res 141:215\u2013222","journal-title":"Behav Brain Res"},{"key":"4_CR162","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1073\/pnas.0336351100","volume":"100","author":"L. Wang","year":"2003","unstructured":"Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003) Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A 100:1393\u20131398","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR163","first-page":"516","volume":"223","author":"A. Weissman","year":"1982","unstructured":"Weissman A, Milne GM, Melvin LS Jr (1982) Cannabimimetic activity from CP-47,497, a derivative of 3-phenylcyclohexanol. J Pharmacol Exp Ther 223:516\u2013523","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR164","first-page":"1235","volume":"273","author":"S.P. Welch","year":"1995","unstructured":"Welch SP, Dunlow LD, Patrick GS, Razdan RK (1995) Characterization of anandamide-and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception. J Pharmacol Exp Ther 273:1235\u20131244","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR165","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0031-9384(02)00725-4","volume":"76","author":"C.M. Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002a) Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 76:241\u2013250","journal-title":"Physiol Behav"},{"key":"4_CR166","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0091-3057(01)00694-3","volume":"71","author":"C.M. Williams","year":"2002","unstructured":"Williams CM, Kirkham TC (2002b) Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine. Pharmacol Biochem Behav 71:333\u2013340","journal-title":"Pharmacol Biochem Behav"},{"key":"4_CR167","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","volume":"65","author":"C.M. Williams","year":"1998","unstructured":"Williams CM, Rogers PJ, Kirkham TC (1998) Hyperphagia in pre-fed rats following oral delta9-THC. Physiol Behav 65:343\u2013346","journal-title":"Physiol Behav"},{"key":"4_CR168","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/35069076","volume":"410","author":"R.I. Wilson","year":"2001","unstructured":"Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588\u2013592","journal-title":"Nature"},{"key":"4_CR169","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"R.I. Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA (2002) Endocannabinoid signaling in the brain. Science 296:678\u2013682","journal-title":"Science"},{"key":"4_CR170","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00008877-199909000-00008","volume":"10","author":"P.J. Winsauer","year":"1999","unstructured":"Winsauer PJ, Lambert P, Moerschbaecher JM (1999) Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol 10:497\u2013511","journal-title":"Behav Pharmacol"},{"key":"4_CR171","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1523\/JNEUROSCI.22-05-01690.2002","volume":"22","author":"T. Yoshida","year":"2002","unstructured":"Yoshida T, Hashimoto K, Zimmer A, Maejima T, Araishi K, Kano M (2002) The cannabinoid CB1 receptor mediates retrograde signals for depolarization-induced suppression of inhibition in cerebellar Purkinje cells. J Neurosci 22:1690\u20131697","journal-title":"J Neurosci"},{"key":"4_CR172","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","volume":"96","author":"A. Zimmer","year":"1999","unstructured":"Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice [see comments]. Proc Natl Acad Sci U S A 96:5780\u20135785","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Handbook of Experimental Pharmacology","Cannabinoids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-26573-2_4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T19:34:24Z","timestamp":1736192064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-26573-2_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["354022565X"],"references-count":172,"URL":"https:\/\/doi.org\/10.1007\/3-540-26573-2_4","relation":{},"subject":[]}}